We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Byotrol Plc | BYOT | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.10 | 01:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.10 | 0.10 | 0.10 | 0.10 | 0.10 |
| Industry Sector |
|---|
| CHEMICALS |
| Top Posts |
|---|
Posted at 15/4/2024 16:40 by maxk Sounds like an all the way out move. 17 million sharesByotrol Plc (AIM: BYOT), the specialist infection prevention and control company, announces that it has received notification that as of 15 April 2024, Lim Teck Lee Investments no longer have an interest in the Company's issued share capital. |
Posted at 12/4/2024 14:32 by sikhthetech 1gw"then in my opinion they need to delist and reduce costs and the sooner the better, rather than limp along in the hope that a big IP payment or a major new customer comes in to save them before the situation becomes critical." It's already critical. It's also obvious that there's 99% chance they will delist. True to form, you're doing your usual comments trying to make out you're right(in hindsight) due to whatever is obviously happening. Pointless now agreeing that it's the best way forward now. They said they were planning to delist months ago, didn't they? Companies which have significant holding by IIs can still do well delisted. Here, Byot have failed to adjust to the market during covid. Lots of jam tomorrow, which you and your mates repeatedly overplayed. If Byot continue down the same route, then it makes no difference if they are listed or not. They are unlikely to come back any stronger. "I personally would rather go the delisting route than sell in the market now." Didn't you say you own some in a SIPP, in which case you will be forced to sell, won't you? |
Posted at 04/4/2024 14:10 by kumbuka mudbath12 Jan '13 - 10:06 - 7 of 12704 0 0 0 The covering analyst at Finncap,Dr.Keith Redpath,suggests that Byotrol might lose £700k over the full year to Mar 31st 2013.This would indicate a loss of just £23k for the current six months. If correct,the losses for the past 3 six monthly trading periods would read:- March 2012= £1377k Sept 2012= £677k March 2013= £23k An impressive trend then,which if maintained, could see BYOT report profits of over £500k for the six months to Sept 2013;although Byotrol house brokers are forecasting a more modest 300k profit for the full year. Reading between the lines,BYOT are looking at a surge in orders.Why else would they be seeking to put in place a significant invoice discounting facility with their bankers. With an IDF in place,Finncap predict BYOT could turn cash flow neutral within the current trading period,possibly then precluding the need for a further large cash raising exercise After several disappointing years,Byotrol seems to be coming good at quite a pace,and imo this pace could quicken Finncap have in place an initial share price target of 15 pence. The share price chart currently looks strong and it could be that such a level is soon tested. A very interesting investment opportunity. |
Posted at 20/3/2024 12:41 by kumbuka BYOTmudbath 12 Jan '13 - 10:06 - 7 of 12570 0 0 0 The covering analyst at Finncap,Dr.Keith Redpath,suggests that Byotrol might lose £700k over the full year to Mar 31st 2013.This would indicate a loss of just £23k for the current six months. If correct,the losses for the past 3 six monthly trading periods would read:- March 2012= £1377k Sept 2012= £677k March 2013= £23k An impressive trend then,which if maintained, could see BYOT report profits of over £500k for the six months to Sept 2013;although Byotrol house brokers are forecasting a more modest 300k profit for the full year. Reading between the lines,BYOT are looking at a surge in orders.Why else would they be seeking to put in place a significant invoice discounting facility with their bankers. With an IDF in place,Finncap predict BYOT could turn cash flow neutral within the current trading period,possibly then precluding the need for a further large cash raising exercise After several disappointing years,Byotrol seems to be coming good at quite a pace,and imo this pace could quicken Finncap have in place an initial share price target of 15 pence. The share price chart currently looks strong and it could be that such a level is soon tested. A very interesting investment opportunity. |
Posted at 20/2/2024 16:41 by football Byotrol - have some positive pointers been missed? LON:(BYOT)HTtps://ww |
Posted at 30/11/2023 13:16 by sikhthetech 1gw#12222 "They have called out disappointing sales in Human Healthcare in H1" I warned about low consumer sales over 3 years ago, when you were misleading readers about sales, Finncap being conservative etc I take it you're not looking for an excuse to sell. That'll be disgraceful behaviour wouldn't it? Try and be honest for once. I see you/your mates are ramping HVO, Polb, SLN, TRMR. Given you portray yourself as a well researched poster, why do the vast majority of your shares crash after you have ramped them? You make a dodgy 2nd hand car salesman sound honest. How many multiple ids do you have and why? sikhthetech - 04 Dec 2022 - 20:27:36 - 10513 of 12322 BYOTROL-CAN DELIVER AMAZING RESULTS - BYOT 1gw, "I think Amazon is a relatively new endeavour for byotrol." It's jam tomorrow. As you very well know during the biggest pandemic to hit the world in 100yrs, Byot had a £590k (yes k) increase in GLOBAL consumer sales. And that was because there was a world wide shortage so people had no alternative. As I said at the time, the pandemic was the golden opportunity presented on a plate but they missed it. Consumer sales a virtually non-existent and therefore jam tomorrow. Your jam tomorrow is endless and repeated every few months for years but never materialised. Btw how did Hycolin do on Amazon despite being originally listed last year??? You're very selective in your comments and have a selective memory depending on your agenda, which currently is ramping. H1 results possibly due this week. Best see what they say rather than baseless jam tomorrow fro (if going by last year) sikhthetech - 07 Jan 2021 - 14:57:21 - 7339 of 8923 1gw, Facts from their H1-2021 accounts published last month. Rest is jam tomorrow. £590k (yes k) increase in global consumer sales when there's the biggest pandemic to hit the globe is not impressive. So with the biggest pandemic to strike in a century they managed £997k (ex-royalty & licensing) of consumer sales! That includes Boots, Homeandcleaning, direct website sales, global sales. Consumer: "H1 revenues more than doubled to £1.01m from £0.41m, including a small amount of IP-based income, versus nil IP income in the comparable period. Gross profit (on products) increased to £0.43m from £0.17m. " "Elsewhere, sales across existing customers all increased in this segment, especially into Japan via our longstanding agents in pet and healthcare." 1gw - 16 Nov 2023 - 12:28:44 - 12222 of 12322 BYOTROL-CAN DELIVER AMAZING RESULTS They have called out disappointing sales in Human Healthcare in H1 |
Posted at 26/10/2023 13:34 by loafofbread 2 weeks before he left he was still buying shares and owns 1.5% so alongside the rest of the BOD plenty to lose unless they sort this out.My take is someone is booking the loss for 28% CGT offset. Byotrol PLC 08 September 2023 Byotrol Plc ("Byotrol" or the "Company") Director Dealing Byotrol Plc (AIM: BYOT), the specialist infection prevention and control company, announces that on the 8(th) of September 2023, the wife of Vivan Pinto, CEO of the Company, purchased a total of 400,000 ordinary shares of 0.25p each ("Ordinary Shares") at an average price of 1.65p per Ordinary Share (the "Purchase"). Following the Purchase, Vivan Pinto's beneficial holding (including those held by his wife) is 2,900,000 Ordinary Shares, representing 0.64% of the total voting rights of the Company. As announced on 28 July 2022, Vivan Pinto subscribed for convertible loan notes in the Company, which if converted would represent an additional 0.7% of the total voting rights of the Company. |
Posted at 25/10/2023 13:38 by riddlerone This is why I and many others on this board appreciate and respect 1gw's research1gw - 23 May 2023 - 15:27:59 - 11175 of 11929 BYOTROL-CAN DELIVER AMAZING RESULTS - BYOT Well done byotrol on (apparently) beating Solvay to the EPA residual virucidal registration. Now does that unlock any minimum guaranteed payments from USCo? Then the following day Byotrol PLC US EPA approves Byotrol24 as long-lasting virucide (5499A) 24/05/2023 3:14pm UK Regulatory (RNS & others) Thank you 1gw for doing what you do.. |
Posted at 08/9/2023 12:56 by loafofbread At least we know where our supply of Brown seaweed will be coming from and our first partnership/developm06 July 2023 Byotrol Plc ("Byotrol" or the "Company") Patent Granted for Novel Anti-viral Seaweed Extract Byotrol Plc (AIM: BYOT), the specialist infection prevention and control company, is pleased to report the approval today of a UK patent following its discovery of unique anti-viral properties of certain enhanced extracts of commonly available brown seaweed. The award is a result of many years of research by Byotrol's technical team at its laboratories at Thornton Science Park, a University of Chester campus, and has been supported by the research scientists at the University of Liverpool led by Professor James Stewart, and by funding received from the Biotechnology and Biological Sciences Research Council (BBSRC) and Innovate UK. The grant of the patent application gives Byotrol validated, valuable and protected intellectual property, to support the development of commercial relationships. In the UK and Europe, seaweed extracts are not as yet approved as active materials for biocidal products, Byotrol's established area of expertise. So, we are now actively exploring alternative applications in very sizeable markets such as over-the-counter (OTC) products for the prophylactic treatment of viral conditions including colds, flu, coronaviruses and cold sores. Byotrol Plc's Chairman, Dr Trevor Francis, comments: "We are delighted to have secured the first patent for our seaweed-based anti-viral technologies. It is another good indication of the quality of our technical capability, and it will most certainly help us as we intensify the search for commercial partners. It also adds to our already significant level of intellectual property in antimicrobials. "This patent further confirms Byotrol's commitment to developing and commercializing natural and sustainable antimicrobial actives." |
Posted at 23/8/2023 07:03 by football Todays RNs WednesdayByotrol PLC Investor Presentation via Investor Meet Company 23/08/2023 7:00am RNS Non-Regulatory TIDMBYOT Byotrol PLC 23 August 2023 RNS Reach Byotrol plc ("Byotrol" or the "Company") Investor Presentation via Investor Meet Company Byotrol plc (AIM: BYOT), the specialist infection prevention and control company is pleased to announce that Vivan Pinto, CEO, David Traynor, Executive Director, and Chris Sedwell, CFO, will provide a live presentation relating to the Full Year Results via Investor Meet Company on 8th Sep 2023 at 11:00am BST. The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 9am the day before the meeting or at any time during the live presentation. Investors can sign up to Investor Meet Company for free and add to meet BYOTROL PLC via: Investors who already follow BYOTROL PLC on the Investor Meet Company platform will automatically be invited. For further information, visit www.byotrolplc.com , follow on twitter @byotrol, or contact |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
